CONTEXT: Previous studies indicate that the population attributable risk (PAR) of bladder cancer for tobacco smoking is 50% to 65% in men and 20% to 30% in women and that current cigarette smoking triples bladder cancer risk relative to never smoking. During the last 30 years, incidence rates have remained stable in the United States in men (123.8 per 100,000 person-years to 142.2 per 100,000 person-years) and women (32.5 per 100,000 person-years to 33.2 per 100,000 person-years); however, changing smoking prevalence and cigarette composition warrant revisiting risk estimates for smoking and bladder cancer. OBJECTIVE: To evaluate the association between tobacco smoking and bladder cancer. DESIGN, SETTING, AND PARTICIPANTS: Men (n = 281,394) and women (n = 186,134) of the National Institutes of Health-AARP (NIH-AARP) Diet and Health Study cohort completed a lifestyle questionnaire and were followed up between October 25, 1995, and December 31, 2006. Previous prospective cohort studies of smoking and incident bladder cancer were identified by systematic review and relative risks were estimated from fixed-effects models with heterogeneity assessed by the I(2) statistic. MAIN OUTCOME MEASURES: Hazard ratios (HRs), PARs, and number needed to harm (NNH). RESULTS: During 4,518,941 person-years of follow-up, incident bladder cancer occurred in 3896 men (144.0 per 100,000 person-years) and 627 women (34.5 per 100,000 person-years). Former smokers (119.8 per 100,000 person-years; HR, 2.22; 95% confidence interval [CI], 2.03-2.44; NNH, 1250) and current smokers (177.3 per 100,000 person-years; HR, 4.06; 95% CI, 3.66-4.50; NNH, 727) had higher risks of bladder cancer than never smokers (39.8 per 100,000 person-years). In contrast, the summary risk estimate for current smoking in 7 previous studies (initiated between 1963 and 1987) was 2.94 (95% CI, 2.45-3.54; I(2) = 0.0%). The PAR for ever smoking in our study was 0.50 (95% CI, 0.45-0.54) in men and 0.52 (95% CI, 0.45-0.59) in women. CONCLUSION: Compared with a pooled estimate of US data from cohorts initiated between 1963 and 1987, relative risks for smoking in the more recent NIH-AARP Diet and Health Study cohort were higher, with PARs for women comparable with those for men.
CONTEXT: Previous studies indicate that the population attributable risk (PAR) of bladder cancer for tobacco smoking is 50% to 65% in men and 20% to 30% in women and that current cigarette smoking triples bladder cancer risk relative to never smoking. During the last 30 years, incidence rates have remained stable in the United States in men (123.8 per 100,000 person-years to 142.2 per 100,000 person-years) and women (32.5 per 100,000 person-years to 33.2 per 100,000 person-years); however, changing smoking prevalence and cigarette composition warrant revisiting risk estimates for smoking and bladder cancer. OBJECTIVE: To evaluate the association between tobacco smoking and bladder cancer. DESIGN, SETTING, AND PARTICIPANTS: Men (n = 281,394) and women (n = 186,134) of the National Institutes of Health-AARP (NIH-AARP) Diet and Health Study cohort completed a lifestyle questionnaire and were followed up between October 25, 1995, and December 31, 2006. Previous prospective cohort studies of smoking and incident bladder cancer were identified by systematic review and relative risks were estimated from fixed-effects models with heterogeneity assessed by the I(2) statistic. MAIN OUTCOME MEASURES: Hazard ratios (HRs), PARs, and number needed to harm (NNH). RESULTS: During 4,518,941 person-years of follow-up, incident bladder cancer occurred in 3896 men (144.0 per 100,000 person-years) and 627 women (34.5 per 100,000 person-years). Former smokers (119.8 per 100,000 person-years; HR, 2.22; 95% confidence interval [CI], 2.03-2.44; NNH, 1250) and current smokers (177.3 per 100,000 person-years; HR, 4.06; 95% CI, 3.66-4.50; NNH, 727) had higher risks of bladder cancer than never smokers (39.8 per 100,000 person-years). In contrast, the summary risk estimate for current smoking in 7 previous studies (initiated between 1963 and 1987) was 2.94 (95% CI, 2.45-3.54; I(2) = 0.0%). The PAR for ever smoking in our study was 0.50 (95% CI, 0.45-0.54) in men and 0.52 (95% CI, 0.45-0.59) in women. CONCLUSION: Compared with a pooled estimate of US data from cohorts initiated between 1963 and 1987, relative risks for smoking in the more recent NIH-AARP Diet and Health Study cohort were higher, with PARs for women comparable with those for men.
Authors: Lisa Gallicchio; Anthony Kouzis; Jeanine M Genkinger; Alyce E Burke; Sandra C Hoffman; Marie Diener-West; Kathy J Helzlsouer; George W Comstock; Anthony J Alberg Journal: Prev Med Date: 2006-02-03 Impact factor: 4.018
Authors: Anthony J Alberg; Anthony Kouzis; Jeanine M Genkinger; Lisa Gallicchio; Alyce E Burke; Sandra C Hoffman; Marie Diener-West; Kathy J Helzlsouer; George W Comstock Journal: Am J Epidemiol Date: 2007-01-04 Impact factor: 4.897
Authors: Terry L Butler; Gary E Fraser; W Lawrence Beeson; Synnøve F Knutsen; R Patti Herring; Jacqueline Chan; Joan Sabaté; Susanne Montgomery; Ella Haddad; Susan Preston-Martin; Hannelore Bennett; Karen Jaceldo-Siegl Journal: Int J Epidemiol Date: 2007-08-27 Impact factor: 7.196
Authors: Marie M Cantwell; James V Lacey; Catherine Schairer; Arthur Schatzkin; Dominique S Michaud Journal: Int J Cancer Date: 2006-11-15 Impact factor: 7.396
Authors: S C Moore; S T Mayne; B I Graubard; A Schatzkin; D Albanes; C Schairer; R N Hoover; M F Leitzmann Journal: Int J Obes (Lond) Date: 2008-01-22 Impact factor: 5.095
Authors: C M Samanic; M Kogevinas; D T Silverman; A Tardón; C Serra; N Malats; F X Real; A Carrato; R García-Closas; M Sala; J Lloreta; N Rothman; M Dosemeci Journal: Occup Environ Med Date: 2007-10-19 Impact factor: 4.402
Authors: Evan Dryson; Andrea 't Mannetje; Chris Walls; Dave McLean; Fiona McKenzie; Milena Maule; Soo Cheng; Chris Cunningham; Hans Kromhout; Paolo Boffetta; Aaron Blair; Neil Pearce Journal: Int J Cancer Date: 2008-03-15 Impact factor: 7.396
Authors: Neal D Freedman; Michael F Leitzmann; Albert R Hollenbeck; Arthur Schatzkin; Christian C Abnet Journal: Lancet Oncol Date: 2008-06-13 Impact factor: 41.316
Authors: Behfar Ehdaie; Helena Furberg; Emily Craig Zabor; Jamie S Ostroff; Shahrokh F Shariat; Bernard H Bochner; Jonathan A Coleman; Guido Dalbagni Journal: BJU Int Date: 2012-05-29 Impact factor: 5.588
Authors: Rafael de Cunto Romero; Wagner A Franca; Cristiane B Dias; Conrado G Pascini; Estevão C Amin; Luis A S Rios Journal: World J Urol Date: 2020-07-30 Impact factor: 4.226
Authors: MacKenzie R Peltier; José M Flores; Philip H Smith; Walter Roberts; Terril L Verplaetse; Kelly E Moore; Robyn Hacker; Lindsay M Oberleitner; Sherry A McKee Journal: Nicotine Tob Res Date: 2020-05-26 Impact factor: 4.244
Authors: Besma Abbaoui; Christopher R Lucas; Ken M Riedl; Steven K Clinton; Amir Mortazavi Journal: Mol Nutr Food Res Date: 2018-08-29 Impact factor: 5.914